Trial intelligence / Profile preview

Tranexamic Acid in Pregnant Women With Placentae Previa

NCT05688111Completed

Sponsor
Hawler Medical University
Start
Dec 2022
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of tranexamic acid in placenta previa (2 arms), sponsored by Hawler Medical University. Primary endpoints: To stope or decrease vaginal bleeding, Prolong pregnancy to 36 weeks and 1 more. Started Dec 2022; status: completed.

02

Drugs

tranexamic acid
03

Conditions

placenta previa

Beyond the preview

Go deeper on NCT05688111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05688111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call